The FDA granted orphan designation to Sanofi US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Discover th ...

Global Anemia Treatment Market size is expected to be worth around USD 19.1 Billion by 2033, from USD 9.7 Billion in 2023, growing at a CAGR of 7.2% Lawrence John Prudour +91 91308 55334 ...

Tremtelectogene empogeditemcel (trem-cel) may make gemtuzumab ozogamicin maintenance safer for patients with high-risk acute myeloid leukemia (AML), according to results of a phase 1/2 trial presented ...

In the autoimmune space, Nurix has identified warm Autoimmune Hemolytic Anemia (wAIHA) as its lead indication for NX-5948. This strategic choice leverages the company's hematology expertise and ...

KBC Group NV boosted its position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 60.1% in the 4th quarter, ...

Immunovant (NASDAQ:IMVT – Get Free Report) had its price target dropped by equities researchers at Guggenheim from $46.00 to ...

Pursuits in autoantibody-driven diseases like myasthenia gravis, warm autoimmune hemolytic anemia, and Sjogren’s disease illustrate a purpose-driven commitment to innovate in areas of ...

These complications can manifest as autoimmune cytopenias, autoimmune hemolytic anemia, and other autoimmune diseases, which can significantly impact patient outcomes. Recent research has focused ...

Expresses differences in erythrocyte size in an individual specimen Used to detect anisocytosis. Increased in immune hemolytic anemia, SS and SC disease, and hereditary spherocytosis ...

The implications of this discovery extend far beyond MG. IgG-mediated pathologies—from autoimmune hemolytic anemia to antibody-dependent enhancement in diseases like dengue fever—could ...